886 related articles for article (PubMed ID: 14594508)
21. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
22. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
[TBL] [Abstract][Full Text] [Related]
24. Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients.
Toungouz M; Quinet C; Thille E; Fourez S; Pradier O; Delville JP; Velu T; Lambermont M
Cytotherapy; 1999; 1(6):447-53. PubMed ID: 20426545
[TBL] [Abstract][Full Text] [Related]
25. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
Lan CY; Liu JH; Xia JC; Zheng LM
Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
[TBL] [Abstract][Full Text] [Related]
26. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes.
Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I
Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cell culture: a simple closed culture system using ficoll, monocytes, and a table-top centrifuge.
Celluzzi CM; Welbon C
J Hematother Stem Cell Res; 2003 Oct; 12(5):575-85. PubMed ID: 14594514
[TBL] [Abstract][Full Text] [Related]
28. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.
Kiertscher SM; Roth MD
J Leukoc Biol; 1996 Feb; 59(2):208-18. PubMed ID: 8603993
[TBL] [Abstract][Full Text] [Related]
29. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device.
Perseghin P; D'Amico G; Dander E; Gaipa G; Dassi M; Biagi E; Biondi A
Transfusion; 2008 Aug; 48(8):1644-9. PubMed ID: 18513258
[TBL] [Abstract][Full Text] [Related]
30. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
Geiger JD; Hutchinson RJ; Hohenkirk LF; McKenna EA; Yanik GA; Levine JE; Chang AE; Braun TM; Mulé JJ
Cancer Res; 2001 Dec; 61(23):8513-9. PubMed ID: 11731436
[TBL] [Abstract][Full Text] [Related]
31. Development of a technology platform for large-scale clinical grade production of DC.
Adamson L; Palmborg A; Svensson A; Lundqvist A; Hansson M; Kiessling R; Masucci G; Mellstedt H; Pisa P
Cytotherapy; 2004; 6(4):363-71. PubMed ID: 16146889
[TBL] [Abstract][Full Text] [Related]
32. Multicenter study on in vitro characterization of dendritic cells.
Eichler H; Nguyen XD; Roelen D; Celluzzi CM; McKenna D; Pamphilon D; Blair A; Read EJ; Takahashi TA; Szczepiorkowski ZM;
Cytotherapy; 2008; 10(1):21-9. PubMed ID: 18202971
[TBL] [Abstract][Full Text] [Related]
33. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
[TBL] [Abstract][Full Text] [Related]
34. Generation of dendritic cells ex vivo: differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors.
Syme RM; Duggan P; Stewart D; Glück S
J Hematother Stem Cell Res; 2001 Oct; 10(5):621-30. PubMed ID: 11672508
[TBL] [Abstract][Full Text] [Related]
35. Impaired circulating myeloid DCs from myeloma patients.
Do TH; Johnsen HE; Kjaersgaard E; Taaning E; Svane IM
Cytotherapy; 2004; 6(3):196-203. PubMed ID: 15203976
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination.
Pedersen AE; Thorn M; Gad M; Walter MR; Johnsen HE; Gaarsdal E; Nikolajsen K; Buus S; Claesson MH; Svane IM
Scand J Immunol; 2005 Feb; 61(2):147-56. PubMed ID: 15683451
[TBL] [Abstract][Full Text] [Related]
37. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.
Babatz J; Röllig C; Löbel B; Folprecht G; Haack M; Günther H; Köhne CH; Ehninger G; Schmitz M; Bornhäuser M
Cancer Immunol Immunother; 2006 Mar; 55(3):268-76. PubMed ID: 16034561
[TBL] [Abstract][Full Text] [Related]
38. Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells.
Xia CQ; Kao KJ
Int Immunol; 2003 Aug; 15(8):1007-15. PubMed ID: 12882838
[TBL] [Abstract][Full Text] [Related]
39. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
40. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
